Funder
Comisión Sectorial de Investigación Científica
Comision Academica de Posgrado
PEDECIBA
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Alper KR, Lotsof HS, Frenken GM et al (1999) Treatment of acute opioid withdrawal with ibogaine. Am J Addict 8:234–242
2. Arıkan MK, Uysal Ö, Gıca Ş, Orhan Ö, İlhan R, Esmeray MT, Bakay H, Metin B, Pogarell O, Turan Ş (2023) REM parameters in drug-free major depressive disorder: a systematic review and meta-analysis. Sleep Med Rev 73:101876
3. Bagal AA, Hough LB, Nalwalk JW, Glick SD (1996) Modulation of morphine-induced antinociception by ibogaine and noribogaine. Brain Res 741:258–262
4. Baumann MH, Pablo J, Ali SF et al (2001a) Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine. Alkaloids Chem Biol 56:79–113
5. Baumann MH, Rothman RB, Pablo JP, Mash DC (2001b) In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. J Pharmacol Exp Ther 297:531–539